Free Trial

Basel Medical Group (BMGL) Competitors

Basel Medical Group logo
$1.61 -0.03 (-1.83%)
As of 10/3/2025 04:00 PM Eastern

BMGL vs. CORBF, QIPT, SERA, BNR, PIII, EUDA, ATPC, BDSX, CCM, and MGRX

Should you be buying Basel Medical Group stock or one of its competitors? The main competitors of Basel Medical Group include Global Cord Blood (CORBF), Quipt Home Medical (QIPT), Sera Prognostics (SERA), Burning Rock Biotech (BNR), P3 Health Partners (PIII), EUDA Health (EUDA), Agape ATP (ATPC), Biodesix (BDSX), Concord Medical Services (CCM), and Mangoceuticals (MGRX). These companies are all part of the "healthcare" industry.

Basel Medical Group vs. Its Competitors

Global Cord Blood (NYSE:CORBF) and Basel Medical Group (NASDAQ:BMGL) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, institutional ownership, media sentiment, dividends, valuation, earnings, profitability and analyst recommendations.

Company Net Margins Return on Equity Return on Assets
Global Cord BloodN/A N/A N/A
Basel Medical Group N/A N/A N/A

In the previous week, Global Cord Blood's average media sentiment score of 0.00 equaled Basel Medical Group'saverage media sentiment score.

Company Overall Sentiment
Global Cord Blood Neutral
Basel Medical Group Neutral

Global Cord Blood has higher revenue and earnings than Basel Medical Group.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Global Cord Blood$196.12M0.62$79.04MN/AN/A
Basel Medical GroupN/AN/AN/AN/AN/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Global Cord Blood
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Basel Medical Group
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Summary

Global Cord Blood and Basel Medical Group tied by winning 1 of the 2 factors compared between the two stocks.

Get Basel Medical Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for BMGL and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BMGL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BMGL vs. The Competition

MetricBasel Medical GroupMedical Services IndustryMedical SectorNASDAQ Exchange
Market Cap$29.71M$8.23B$6.12B$10.58B
Dividend YieldN/A2.80%5.65%4.70%
P/E RatioN/A75.2686.9626.71
Price / SalesN/A40.93605.42130.98
Price / CashN/A23.0137.9061.31
Price / BookN/A6.7612.556.55
Net IncomeN/A$250.93M$3.31B$277.50M
7 Day Performance-8.52%2.29%4.28%2.42%
1 Month Performance-20.30%3.27%6.90%8.63%
1 Year PerformanceN/A10.51%70.54%31.60%

Basel Medical Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BMGL
Basel Medical Group
N/A$1.61
-1.8%
N/AN/A$29.71MN/A0.0036Positive News
CORBF
Global Cord Blood
N/A$1.00
+400.0%
N/A-42.9%$121.55M$196.12M0.001,200Gap Up
QIPT
Quipt Home Medical
1.6328 of 5 stars
$2.68
flat
$3.15
+17.5%
-6.8%$116.43M$238.38M-11.171,200Positive News
SERA
Sera Prognostics
0.8241 of 5 stars
$3.09
+4.7%
N/A-54.9%$111.14M$108K-3.64120Positive News
BNR
Burning Rock Biotech
0.4416 of 5 stars
$9.32
+2.3%
N/A+146.4%$100.29M$70.67M-4.911,390
PIII
P3 Health Partners
2.5276 of 5 stars
$9.76
-4.2%
$16.25
+66.5%
-54.2%$70.17M$1.50B-0.21500
EUDA
EUDA Health
1.2121 of 5 stars
$1.70
+0.6%
N/A-42.1%$63.17M$4.01M0.002Gap Up
ATPC
Agape ATP
0.8141 of 5 stars
$1.26
-2.2%
N/A-36.0%$63.11M$1.32M-3.0840News Coverage
Positive News
Short Interest ↓
BDSX
Biodesix
3.6876 of 5 stars
$7.75
-3.2%
$32.50
+319.4%
-77.1%$56.81M$71.32M-1.34220Short Interest ↓
CCM
Concord Medical Services
1.3301 of 5 stars
$6.30
+1.0%
N/A-15.3%$27.34M$52.60M0.00970Short Interest ↓
Gap Down
MGRX
Mangoceuticals
0.6957 of 5 stars
$2.16
-4.0%
N/A-95.4%$22.77M$620K-0.563

Related Companies and Tools


This page (NASDAQ:BMGL) was last updated on 10/5/2025 by MarketBeat.com Staff
From Our Partners